|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leroy X, Zini L, Buob D, Ballereau C,
Villers A and Aubert S: Renal cell carcinoma with rhabdoid
features: an aggressive neoplasm with overexpression of p53. Arch
Pathol Lab Med. 131:102–106. 2007.PubMed/NCBI
|
|
3
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patel C, Ahmed A and Ellsworth P: Renal
cell carcinoma: a reappraisal. Urol Nurs. 32:182–190.
2012.PubMed/NCBI
|
|
5
|
Wei C, Wu S, Li X, et al: High expression
of FER tyrosine kinase predicts poor prognosis in clear cell renal
cell carcinoma. Oncol Lett. 5:473–478. 2013.PubMed/NCBI
|
|
6
|
Yu XY, Zhang Z, Liu J, Zhan B and Kong CZ:
MicroRNA-141 is downregulated in human renal cell carcinoma and
regulates cell survival by targeting CDC25B. Onco Targets Ther.
6:349–354. 2013.PubMed/NCBI
|
|
7
|
Zhai Q, Zhou L, Zhao C, et al:
Identification of miR-508-3p and miR-509-3p that are associated
with cell invasion and migration and involved in the apoptosis of
renal cell carcinoma. Biochem Biophys Res Commun. 419:621–626.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu Z, Ni L, Chen D, et al: Identification
of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol.
44:669–677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang XW, Zhang LJ, Huang XH, et al:
miR-145 suppresses cell invasion in hepatocellular carcinoma cells:
miR-145 targets ADAM17. Hepatol Res. 4:551–559. 2014. View Article : Google Scholar
|
|
10
|
Xi Y: MicroRNA: A New Player for Cancer
Chemoprevention. J Integr Oncol. 2:2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xi JJ: MicroRNAs in Cancer. Cancer Treat
Res. 158:119–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bian HB, Pan X, Yang JS, Wang ZX and De W:
Upregulation of microRNA-451 increases cisplatin sensitivity of
non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res.
30:202011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bergamaschi A and Katzenellenbogen BS:
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes
breast cancer cell survival and endocrine resistance. Oncogene.
31:39–47. 2012. View Article : Google Scholar
|
|
14
|
Rani SB, Rathod SS, Karthik S, Kaur N,
Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive
RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro
Oncol. 15:1302–1316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
16
|
Yoshino H, Enokida H, Itesako T, et al:
Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in
renal cell carcinoma. Cancer Sci. 104:1567–1574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou L, Chen J, Li Z, et al: Integrated
profiling of microRNAs and mRNAs: microRNAs located on Xq27.3
associate with clear cell renal cell carcinoma. PloS One.
5:e152242010. View Article : Google Scholar
|
|
18
|
Zhang J, Yang Y, Yang T, et al:
microRNA-22, downregulated in hepatocellular carcinoma and
correlated with prognosis, suppresses cell proliferation and
tumourigenicity. Br J Cancer. 103:1215–1220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kefas B, Godlewski J, Comeau L, et al:
microRNA-7 inhibits the epidermal growth factor receptor and the
Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun H, Li QW, Lv XY, et al: MicroRNA-17
post-transcriptionally regulates polycystic kidney disease-2 gene
and promotes cell proliferation. Mol Biol Rep. 37:2951–2958. 2010.
View Article : Google Scholar
|
|
21
|
Yamamura S, Saini S, Majid S, et al:
MicroRNA-34a suppresses malignant transformation by targeting c-Myc
transcriptional complexes in human renal cell carcinoma.
Carcinogenesis. 33:294–300. 2012. View Article : Google Scholar :
|
|
22
|
Redova M, Poprach A, Besse A, et al:
MiR-210 expression in tumor tissue and in vitro effects of its
silencing in renal cell carcinoma. Tumour Biol. 34:481–491. 2013.
View Article : Google Scholar
|
|
23
|
Zhang H, Guo Y, Shang C, Song Y and Wu B:
miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
Urology. 80:1298–1302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakada C, Matsuura K, Tsukamoto Y, et al:
Genome-wide microRNA expression profiling in renal cell carcinoma:
significant down-regulation of miR-141 and miR-200c. J Pathol.
216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boguslawska J, Wojcicka A,
Piekielko-Witkowska A, Master A and Nauman A: MiR-224 targets the
3′UTR of type 1 5′-iodothyronine deiodinase possibly contributing
to tissue hypothyroidism in renal cancer. PloS One. 6:e245412011.
View Article : Google Scholar
|
|
26
|
Wang R, Wang ZX, Yang JS, Pan X, De W and
Chen LB: MicroRNA-451 functions as a tumor suppressor in human
non-small cell lung cancer by targeting ras-related protein 14
(RAB14). Oncogene. 30:2644–2658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bandres E, Bitarte N, Arias F, et al:
microRNA-451 regulates macrophage migration inhibitory factor
production and proliferation of gastrointestinal cancer cells. Clin
Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Godlewski J, Nowicki MO, Bronisz A, et al:
MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to
metabolic stress in glioma cells. Mol Cell. 37:620–632. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim VN: MicroRNA biogenesis: coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hammond SM: RNAi, microRNAs, and human
disease. Cancer Chemother Pharmacol. 58(Suppl 1): s63–s68. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Drakaki A and Iliopoulos D: MicroRNA gene
networks in oncogenesis. Curr Genomics. 10:35–41. 2009. View Article : Google Scholar : PubMed/NCBI
|
